Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome
スポンサーリンク
概要
著者
-
Bessho M
Saitama Medical School Saitama
-
BESSHO Masami
First Department of Internal Medicine, Saitama Medical School
-
HIRASHIMA Kunitake
First Department of Internal Medicine, Saitama Medical School
-
KUSUMOTO Shuya
First Department of Internal Medicine, Saitama Medical School
-
Kusumoto Shuya
First Department Of Internal Medicine Saitama Medical School
-
Kusumoto S
Saitama Medical School Saitama Jpn
-
YAGASAKI Fumiharu
First Department of Internal Medicine, Saitama Medical School
-
Bessho Masami
First Department Of Internal Medicine Saitama Medical School
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University Hospital
-
Yagasaki Fumiharu
First Department Of Internal Medicine Saitama Medical School
-
KAWAI Nobutaka
First Department of Internal Medicine, Saitama Medical School
-
TAKAHASHI Takashi
First Department of Internal Medicine, Saitama Medical School
-
ENDO Kazuhiro
First Department of Internal Medicine, Saitama Medical School
-
TAKAHASHI Miki
First Department of Internal Medicine, Saitama Medical School
-
ITOH Yoshihiro
First Department of Internal Medicine, Saitama Medical School
-
MUROHASHI Ikuo
First Department of Internal Medicine, Saitama Medical School
-
Itoh Yoshihiro
First Department Of Internal Medicine Saitama Medical School
-
Murohashi Ikuo
First Department Of Internal Medicine Saitama Medical School
-
Kawai Nobutaka
First Department Of Internal Medicine Saitama Medical School
-
Endo Kazuhiro
First Department Of Internal Medicine Saitama Medical School
-
Hirashima Kunitake
First Department Of Internal Medicine Saitama Medical School
-
Takahashi Miki
First Department Of Internal Medicine Saitama Medical School
-
Takahashi Takashi
First Department Of Internal Medicine Saitama Medical School
-
Yagasaki Fumiharu
Department Of Public Health Shimane University Faculty Of Medicine
-
Fujita Yasuyuki
Department Of Public Health Shimane University Faculty Of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Effects of Z-100 on Mice Exposed to γ-Irradiation: A preliminary report
- A Patient with Severe Hypertriglyceridemia Associated with Anemia and Hypoalbuminemia
- Apoptosis of Endothelial Cells may be Mediated by Genes of Peroxisome Proliferator-activated Receptor γ1 (PPAR γ1) and PPARα Genes
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia
- Long-term Follow-up of Patients with Aplastic Anemia and Refractory Anemia Responding to Combination Therapy with Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin
- Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome
- Alterations in the colorectal carcinoma gene and protein in a novel human myeloid leukemia cell line with trisomy 18 established from overt leukemia after myelodysplastic syndrome
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- p53-independent induction of p21 (WAF1/CIP1) during differentiation of HL-60 cells by tumor necrosis factor alpha
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Association Between Feeling Upon Awakening and Use of Information Technology Devices in Japanese Children
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study